Literature DB >> 10483373

Shikonin, an ingredient of Lithospermum erythrorhizon induced apoptosis in HL60 human premyelocytic leukemia cell line.

Y Yoon1, Y O Kim, N Y Lim, W K Jeon, H J Sung.   

Abstract

Apoptosis is a new therapeutic target of cancer research. Shikonin isolated from Lithospermum erythrorhizon, a traditional oriental medicinal herb, was observed to induce apoptosis in HL60 human premyelocytic leukemia cell line. Shikonin induced DNA fragmentation into the multiples of 180 bp and increased the percentage of hypodiploid cells in flow cytometry after propidium iodide staining. The increase of apoptotic cells was preceded by the activation of caspase-3, which was reported to play a central role in apoptotic process. The DNA fragmentation induced by shikonin was completely inhibited by the pretreatment of z-VAD-fmk, a specific inhibitor of caspase, clearly showing that the mode of cell death is apoptotic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483373     DOI: 10.1055/s-1999-14010

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  15 in total

1.  The Effect of Gromwell (Lithospermum erythrorhizon) Extract on the Stratum Corneum Hydration and Ceramides Content in Atopic Dermatitis Patients.

Authors:  Hee Ryung Cho; Yunhi Cho; Juyoung Kim; Dae Bang Seo; Sung Han Kim; Sang Jun Lee; Nack In Kim
Journal:  Ann Dermatol       Date:  2008-06-30       Impact factor: 1.444

2.  In vitro and in vivo antitumor effects of acetylshikonin isolated from Arnebia euchroma (Royle) Johnst (Ruanzicao) cell suspension cultures.

Authors:  Wenbi Xiong; Gang Luo; Liming Zhou; Yun Zeng; Wenji Yang
Journal:  Chin Med       Date:  2009-07-11       Impact factor: 5.455

3.  Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo.

Authors:  Huanjie Yang; Ping Zhou; Hongbiao Huang; Di Chen; Ningfang Ma; Qiuzhi Cindy Cui; Shouxing Shen; Weihua Dong; Xiaoyan Zhang; Wen Lian; Xuejun Wang; Q Ping Dou; Jinbao Liu
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

4.  Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.

Authors:  Qiang Wang; Jing Wang; Jiayou Wang; Xiaoli Ju; Heng Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

5.  Anti-cancer natural products isolated from chinese medicinal herbs.

Authors:  Wen Tan; Jinjian Lu; Mingqing Huang; Yingbo Li; Meiwan Chen; Guosheng Wu; Jian Gong; Zhangfeng Zhong; Zengtao Xu; Yuanye Dang; Jiajie Guo; Xiuping Chen; Yitao Wang
Journal:  Chin Med       Date:  2011-07-22       Impact factor: 5.455

6.  Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation.

Authors:  Wenjuan Li; Chunjing Zhang; Amy Ren; Teena Li; Rong Jin; Guohong Li; Xin Gu; Runhua Shi; Yunfeng Zhao
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

7.  Anticancer agent shikonin is an incompetent inducer of cancer drug resistance.

Authors:  Hao Wu; Jiansheng Xie; Qiangrong Pan; Beibei Wang; Danqing Hu; Xun Hu
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Topoisomerase I inhibitors, shikonin and topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells.

Authors:  Feng-Lei Zhang; Ping Wang; Yun-Hui Liu; Li-Bo Liu; Xiao-Bai Liu; Zhen Li; Yi-Xue Xue
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

9.  Anxiolytic and Hypnotic Effects of Aqueous and Ethanolic Extracts of Aerial Parts of Echium italicum L. in Mice.

Authors:  Hossein Hosseinzadeh; Shabnam Shahandeh; Shabnam Shahsavand
Journal:  Jundishapur J Nat Pharm Prod       Date:  2012-05-28

10.  Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells.

Authors:  Sunil Sagar; Luke Esau; Basem Moosa; Niveen M Khashab; Vladimir B Bajic; Mandeep Kaur
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.